Table 2 Personal and clinical data of patients at enrollment
From: Vitamins (A, C and E) and oxidative status of hemodialysis patients treated with HFR and HFR-Supra
| Â | All | Arm A | Arm B |
|---|---|---|---|
n | 41 | 21 | 20 |
Age (years) | 70 (61–76) | 73 (56–79) | 67 (65–73) |
Dialysis vintage (months) | 69 (35–153) | 107 (53–164) | 60 (29–135) |
Gender | M = 26 (63 %) | M = 12 (57 %) | M = 14 (70 %) |
F = 15 (37 %) | F = 9 (43 %) | F = 6 (30 %) | |
Albumin (mg/dL) | 3.6 (3.4–3.9) | 3.6 (3.4–4.0) | 3.7 (3.5–3.9) |
Mean Body weight (kg) | M = 63.5 ± 9.6 | M = 63.2 ± 7.9 | M = 63.8 ± 11.2 |
F = 56.5 ± 10.5 | F = 53.6 ± 10.2 | F = 60.7 ± 10.2 | |
BMI | M = 23.7 ± 3.4 | M = 24.1 ± 2.3 | M = 23.3 ± 4.2 |
F = 23.8 ± 4.4 | F = 23.0 ± 4.1 | F = 25.0 ± 4.8 | |
Cardiovascular disease | 59Â % | 62Â % | 55Â % |
Hypertension | 78Â % | 81Â % | 75Â % |
Diabetes | 22Â % | 19Â % | 25Â % |
Charlson Comorbidity Score | 6 (6–7) | 6 (5–7) | 6 (6–7) |
Previous dialysis treatment | BHD = 15 (37 %) | BHD = 8 (38 %) | BHD = 7 (35 %) |
HDF = 10 (24 %) | HDF = 4 (19 %) | HDF = 6 (30 %) | |
HFR = 16 (39 %) | HFR = 9 (43 %) | HFR = 7 (35 %) |